{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:13:38Z","timestamp":1759331618550,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.lungcan.2022.06.017","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T19:24:07Z","timestamp":1656789847000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment \u2013 A multicenter analysis"],"prefix":"10.1016","volume":"170","author":[{"given":"Nikolaj","family":"Frost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Roeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janna-Lisa","family":"Velthaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Raspe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Olive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schmittel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Onken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"L\u00fcders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Senger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Loges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik P.","family":"Modest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Groh\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2022.06.017_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2022.06.017_b0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC lung cancer staging project","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2022.06.017_b0030","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non-small cell lung cancer-A consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2022.06.017_b0035","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1991.9.9.1618","article-title":"Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience","volume":"9","author":"Albain","year":"1991","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2022.06.017_b0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.lungcan.2022.06.017_b0045","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.lungcan.2022.06.017_b0050","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy Vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0055","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"issue":"25","key":"10.1016\/j.lungcan.2022.06.017_b0060","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2022.06.017_b0070","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.cllc.2018.01.007","article-title":"Non-small-cell lung cancer with brain metastasis at presentation","volume":"19","author":"Waqar","year":"2018","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2022.06.017_b0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.lungcan.2014.06.001","article-title":"Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival","volume":"85","author":"Gray","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2022.06.017_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2022.06.017_b0085","unstructured":"Leitlinienprogramm Onkologie. S3-Leitlinie Pr\u00e4vention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. 2018. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Lungenkarzinom\/LL_Lungenkarzinom_Langversion_1.0.pdf2022-FEB-02)."},{"key":"10.1016\/j.lungcan.2022.06.017_b0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.lungcan.2018.09.021","article-title":"Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients","volume":"125","author":"Frost","year":"2018","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2022.06.017_b0095","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/cancers13081893","article-title":"Management of synchronous extrathoracic oligometastatic non-small cell lung cancer","volume":"13","author":"Jones","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.lungcan.2022.06.017_b0100","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ejcts\/ezz384","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2022.06.017_b0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin. Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2022.06.017_b0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ejcts\/ezr042","article-title":"Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?","volume":"41","author":"Mordant","year":"2012","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2022.06.017_b0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejca.2008.10.033","article-title":"Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1\u20133 brain metastases: results of a matched pair analysis","volume":"45","author":"Rades","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2022.06.017_b0120","first-page":"CD012086","article-title":"Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis","volume":"8","author":"Fuentes","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"21","key":"10.1016\/j.lungcan.2022.06.017_b0125","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.lungcan.2022.06.017_b0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2022.06.017_b0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2022.06.017_b0140","doi-asserted-by":"crossref","unstructured":"M.R. Quigley, N. Bello, D. Jho, R. Fuhrer, S. Karlovits, F.J. Buchinsky. Estimating the additive benefit of surgical excision to stereotactic radiosurgery in the management of metastatic brain disease, Neurosurgery 76(6) 2015 707-12; discussion 12-3.","DOI":"10.1227\/NEU.0000000000000707"},{"issue":"4","key":"10.1016\/j.lungcan.2022.06.017_b0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamaoncol.2015.1145","article-title":"Japanese Radiation Oncology Study Group I. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: secondary analysis of the JROSG 99\u20131 randomized clinical trial","volume":"1","author":"Aoyama","year":"2015","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.lungcan.2022.06.017_b0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.lungcan.2022.06.017_b0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/JNS\/2008\/108\/2\/0248","article-title":"Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa","volume":"108","author":"Suki","year":"2008","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.lungcan.2022.06.017_b0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2015.11.022","article-title":"Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery","volume":"94","author":"Johnson","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.lungcan.2022.06.017_b0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cllc.2019.06.003","article-title":"Clinical characteristics, molecular phenotyping, and management of isolated adrenal metastases from lung cancer","volume":"20","author":"Mazzella","year":"2019","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2022.06.017_b0170","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","article-title":"Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients","volume":"107","author":"Chen","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2022.06.017_b0185","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cncr.30000","article-title":"Risk of brain metastases in patients with nonmetastatic lung cancer: analysis of the metropolitan Detroit surveillance, epidemiology, and end results (SEER) data","volume":"122","author":"Goncalves","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2022.06.017_b0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fonc.2018.00088","article-title":"Brain metastases in oncogene-addicted non-small cell lung cancer patients: incidence and treatment","volume":"8","author":"Remon","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.017_b0195","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2022.06.017_b0200","unstructured":"D.S. Ettinger, D.E. Wood, D.L. Aisner, et al. Non-Small Cell Lung Cancer \u2013 NCCN Evidence Blocks, Version 1.2022. 2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl_blocks.pdf (accessed 2022-Jan-26."},{"issue":"1","key":"10.1016\/j.lungcan.2022.06.017_b0205","article-title":"Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.lungcan.2022.06.017_b0210","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222005396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222005396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:03:13Z","timestamp":1759237393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222005396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":42,"alternative-id":["S0169500222005396"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.017","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment \u2013 A multicenter analysis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}